GlassScriptPhysician profile
Ellis V Hedaya
NPI 1528032596
$7,775.50
in general payments reported to CMS, 2019-2025
53 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $22.30 · 2021: $408 · 2022: $1,418 · 2023: $1,563 · 2024: $2,188 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,290 · Education: $240 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,289.67 |
| Education | $239.76 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,368.08 | 2021-2025 | |
| Biogen, INC. | $559.28 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Alexion Pharmaceuticals, INC. | $481.33 | 2019-2025 | Ultomiris, Soliris |
| Ucb, INC. | $462.73 | 2021-2025 | Nayzilam, Rystiggo, Zilbrysq |
| Emd Serono, INC. | $459.18 | 2021-2025 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $423.35 | 2019-2025 | |
| Lilly USA, LLC | $313.03 | 2021-2024 | Emgality, Amyvid, Kisunla |
| Amgen INC. | $265.99 | 2019-2024 | Uplizna, Aimovig |
| Pfizer INC. | $235.44 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $223.83 | 2022 | |
| Celgene Corporation | $199.55 | 2019-2025 | Zeposia |
| Sk Life Science, INC. | $198.20 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $184.35 | 2022-2024 | Ingrezza |
| Acadia Pharmaceuticals INC | $183.55 | 2022-2025 | Nuplazid, Daybue |
| Genzyme Corporation | $175.02 | 2022-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $167.92 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $149.37 | 2024-2025 | Rexulti |
| Lundbeck LLC | $147.90 | 2022-2024 | Vyepti |
| Tg Therapeutics, INC. | $124.06 | 2023-2025 | |
| Argenx US, INC. | $113.91 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Impel Pharmaceuticals INC. | $92.48 | 2022-2023 | Trudhesa |
| Teva Pharmaceuticals USA, INC. | $89.62 | 2022-2024 | Austedo, Austedo Xr |
| Kyowa Kirin, INC. | $83.53 | 2022-2024 | Nourianz |
| Genentech USA, INC. | $77.16 | 2021-2023 | Ocrevus |
| Ani Pharmaceuticals, INC. | $74.01 | 2023-2024 | Purified Cortrophin Gel |
| Neurelis, INC. | $72.86 | 2023-2024 | Valtoco |
| Azurity Pharmaceuticals, INC. | $69.26 | 2023-2025 | Horizant, Horizant |
| Amneal Pharmaceuticals LLC | $63.41 | 2023-2025 | Rytary, Crexont |
| Supernus Pharmaceuticals, INC. | $60.26 | 2019 | |
| Horizon Therapeutics Plc | $58.77 | 2023 | Uplizna |
| Cycle Pharmaceuticals INC | $56.47 | 2024-2025 | Tascenso Odt |
| Avion Pharmaceuticals | $49.90 | 2022-2023 | Dhivy |
| Alnylam Pharmaceuticals INC. | $49.51 | 2023-2024 | Amvuttra, Onpattro |
| Forte Bio-Pharma LLC | $44.44 | 2025 | Tanlor |
| Janssen Biotech, INC. | $27.06 | 2025 | |
| Corium, LLC | $26.37 | 2023 | Adlarity |
| Harmony Biosciences LLC | $26.15 | 2023 | Wakix |
| Mallinckrodt Hospital Products INC. | $25.35 | 2022 | |
| Axsome Therapeutics, INC. | $25.01 | 2025 | Symbravo |
| Vanda Pharmaceuticals INC. | $24.96 | 2024 | Ponvory |
| Banner Life Sciences, LLC | $23.49 | 2023 | |
| Allergan, INC. | $22.30 | 2020 | |
| Kedrion Biopharma, INC. | $22.24 | 2024 | Kedrab, Albuked, Koate |
| Upsher-Smith Laboratories LLC | $21.66 | 2022 | |
| Tanabe Pharma America, INC. | $20.14 | 2023 | |
| Csl Behring | $20.13 | 2023 | Hizentra |
| Impel Pharmaceuticals LLC | $18.56 | 2025 | Trudhesa |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Cala Health, INC. | $17.63 | 2023 | Cala Trio |
| Biohaven Pharmaceuticals, INC. | $17.42 | 2021 | |
| Grifols USA, LLC | $15.44 | 2021 | |
| Currax Pharmaceuticals LLC | $13.27 | 2023 | Onzetra Xsail |
| Collegium Pharmaceutical, INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellis Hedaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.